Literature DB >> 31697280

Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)†.

Shalini Desai, Allison McGeer, Caroline Quach-Thanh, Denise Elliott.   

Abstract

Entities:  

Year:  2010        PMID： 31697280      PMCID： PMC6802447          DOI： 10.14745/ccdr.v36i00a12

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN： 1188-4169


× No keyword cloud information.
  29 in total

1.  Current methods of the US Preventive Services Task Force: a review of the process.

Authors:  R P Harris; M Helfand; S H Woolf; K N Lohr; C D Mulrow; S M Teutsch; D Atkins
Journal:  Am J Prev Med       Date:  2001-04       Impact factor: 5.043

2.  An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on recommended use of pneumococcal conjugate vaccine.

Authors: 
Journal:  Can Commun Dis Rep       Date:  2002-01-15

3.  Immunogenicity, safety and tolerability of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months post-natally to pre- and full-term infants.

Authors:  Susanna Esposito; Lorenza Pugni; Samantha Bosis; Alice Proto; Laura Cesati; Ciro Bianchi; Carolyn Cimino; Fabio Mosca; Nicola Principi
Journal:  Vaccine       Date:  2005-02-25       Impact factor: 3.641

4.  Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT).

Authors:  D Scheifele; S Halperin; L Pelletier; J Talbot
Journal:  Clin Infect Dis       Date:  2000-07-24       Impact factor: 9.079

5.  Effectiveness of pneumococcal conjugate vaccine using a 2+1 infant schedule in Quebec, Canada.

Authors:  Geneviève Deceuninck; Philippe De Wals; Nicole Boulianne; Gaston De Serres
Journal:  Pediatr Infect Dis J       Date:  2010-06       Impact factor: 2.129

6.  Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.

Authors:  Cynthia G Whitney; Tamar Pilishvili; Monica M Farley; William Schaffner; Allen S Craig; Ruth Lynfield; Ann-Christine Nyquist; Kenneth A Gershman; Marietta Vazquez; Nancy M Bennett; Arthur Reingold; Ann Thomas; Mary P Glode; Elizabeth R Zell; James H Jorgensen; Bernard Beall; Anne Schuchat
Journal:  Lancet       Date:  2006-10-28       Impact factor: 79.321

7.  Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population.

Authors:  Marc G Romney; Mark W Hull; Réka Gustafson; Jat Sandhu; Sylvie Champagne; Titus Wong; Anouf Nematallah; Sara Forsting; Patricia Daly
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

8.  Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Authors:  Lauri A Hicks; Lee H Harrison; Brendan Flannery; James L Hadler; William Schaffner; Allen S Craig; Delois Jackson; Ann Thomas; Bernard Beall; Ruth Lynfield; Arthur Reingold; Monica M Farley; Cynthia G Whitney
Journal:  J Infect Dis       Date:  2007-10-04       Impact factor: 5.226

9.  Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.

Authors:  James D Kellner; Otto G Vanderkooi; Judy MacDonald; Deirdre L Church; Gregory J Tyrrell; David W Scheifele
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

10.  Essential criteria for evaluation of pneumococcal conjugate vaccine candidates.

Authors:  Peter Paradiso
Journal:  Vaccine       Date:  2009-08-21       Impact factor: 3.641
View more
  3 in total

1.  Invasive bacterial diseases in northern Canada, 1999 to 2018.

Authors:  Grace Huang; Irene Martin; Raymond S Tsang; Walter H Demczuk; Gregory J Tyrrell; Y Anita Li; Catherine Dickson; Francesca Reyes-Domingo; Susan G Squires
Journal:  Can Commun Dis Rep       Date:  2021-11-10

2.  Estimating population-based incidence of community-acquired pneumonia and acute otitis media in children and adults in Ontario and British Columbia using health administrative data, 2005-2018: a Canadian Immunisation Research Network (CIRN) study.

Authors:  Sharifa Nasreen; Jun Wang; Manish Sadarangani; Jeffrey C Kwong; Caroline Quach; Natasha S Crowcroft; Sarah E Wilson; Allison McGeer; Shaun K Morris; James D Kellner; Beate Sander; Julianne V Kus; Linda Hoang; Fawziah Marra; Shaza A Fadel
Journal:  BMJ Open Respir Res       Date:  2022-06

3.  Clinical Presentations and Outcomes of Children in Canada With Recurrent Invasive Pneumococcal Disease From the IMPACT Surveillance Network.

Authors:  Yousif Murad; Te-Yu Hung; Manish Sadarangani; Shaun K Morris; Nicole Le Saux; Otto G Vanderkooi; James D Kellner; Gregory J Tyrrell; Irene Martin; Walter Demczuk; Scott A Halperin; Julie A Bettinger; N Bridger; Cheryl Foo; S A Halperin; K A Top; R Thibeault; D Moore; J Papenburg; M Lebel; N Le Saux; S Morris; J Embree; B Tan; Athena McConnell; T Jadavji; C Constantinescu; W Vaudry; D Scheifele; M Sadarangani; J Bettinger; L Sauvé
Journal:  Pediatr Infect Dis J       Date:  2022-04-01       Impact factor: 3.806
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.